Skip to Content
  • 3.7
    Impact Factor
  • 4.2
    CiteScore
  • 22 days
    Submission to First Decision
  • 3 days
    Acceptance to Publication

Diseases

Diseases is an international, peer-reviewed, open access, multidisciplinary journal with focus on research on human diseases and conditions, published monthly online by MDPI. 
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, ESCI (Web of Science), PubMed, PMC, CAPlus / SciFinder, and other databases.
  • Journal Rank: JCR - Q2 (Medicine, Research and Experimental) / CiteScore - Q1 (General Medicine)
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 21.6 days after submission; acceptance to publication is undertaken in 2.6 days (median values for papers published in this journal in the first half of 2026).
  • Recognition of Reviewers: Reviewers whose reports are timely and of high quality receive an APC discount voucher for a future publication in an MDPI journal. Become a reviewer.
  • Sections: published in 8 topical sections.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (1,927)

  • Article
  • Open Access

Background/Objectives: Social support and spiritual well-being may matter for the quality of life (QoL) of women with cervical cancer in sub-Saharan Africa, but their interrelations are rarely studied. This study examined their associations with QoL in Tanzanian women. Methods: In this cross-sectional study, 499 women recruited consecutively at two Tanzanian cancer centers completed the EORTC QLQ-C30, the EORTC QLQ-SWB32 and a Kiswahili ENRICHD Social Support Instrument (ESSI). Associations were examined using multivariable regression and mediation analysis. Results: In adjusted regression (n = 460), higher social support (B = 0.80 per ESSI point, 95% CI 0.49–1.11) and higher global spiritual well-being (B = 0.11, 95% CI 0.04–0.17) were associated with higher global QoL. The statistical indirect association via spiritual well-being was small (ab = 0.19, 95% CI 0.05–0.34; 19.2% of the total association) and robust to multiple imputation and additional covariates, but it was present at only one center (difference −0.42, 95% CI −0.78 to −0.06) and could not be distinguished from reverse orderings. Neither variable was positively associated with the QLQ-C30 summary score. Conclusions: Both social support and spiritual well-being were associated with women’s global appraisal of QoL rather than with functioning or symptoms; longitudinal studies are needed to establish direction and clinical relevance.

Diseases

19 November 2026

Flow diagram of participant recruitment, inclusion and analytic samples by study site. All eligible women who were approached consented to participate and completed the questionnaires; reasons for exclusion from the regression and mediation analyses (missing data) are shown.
  • Article
  • Open Access

Background: Hospitalised exacerbations of non-cystic fibrosis bronchiectasis are clinically heterogeneous, yet inpatient microbiology and management remain incompletely characterised. Methods: We retrospectively analysed 53 consecutive hospitalisations in 47 adults (2023–2024), describing respiratory severity, microbiological findings, antimicrobial exposure, corticosteroid use and length of stay (LOS), without a comparator group. Results: Acute respiratory failure was documented in 12/53 episodes (22.6%), and Pseudomonas aeruginosa was isolated in 19/53 (35.8%). An exploratory four-domain classification (bacteria, nontuberculous mycobacteria, fungi and viruses), incorporating historical and acute findings, identified ≥2 domains in 24/53 episodes (45.3%); median LOS was 18.5 versus 15 days for ≥2 versus 0–1 domains. Intravenous antibacterials were recorded in 51/53 episodes (96.2%) and inhaled amikacin in 28/53 (52.8%). Median systemic antibacterial treatment duration, calculated from recorded concurrent antibiotic courses, was 11 days during hospitalisation and 11.5 days including documented pretreatment. Systemic corticosteroids were recorded in 28/53 episodes (52.8%), including 15/30 without documented COPD or asthma. Overall median LOS was 16 days (IQR 12–20), with one in-hospital death (1.9%). Conclusions: Hospitalised exacerbations involved heterogeneous microbiological findings and frequent acute inhaled antibiotic and systemic corticosteroid use. The overlap–LOS contrast is descriptive, not prognostic, and reconstructed durations cannot establish treatment appropriateness. Prospective studies should assess prescribing indications, microbiological context and clinical response.

Diseases

18 November 2026

Historical colonisation and acute isolation of Pseudomonas aeruginosa (n = 53).
  • Review
  • Open Access

Background: Macrocephaly may encompass a broad array of clinical conditions, but no decisional algorithms exist for its assessment and management. The clinician–geneticist alliance in the specific context of overgrowth syndromes may be of interest for shaping a proper diagnostic path. At present, the literature regarding a genetic link of macrocephaly with pathogenic SETD2 variants is limited. Case Presentation: We report a young man with macrocephaly first noted in infancy, confirmed in every stage of his life, combined with speech delay and moderate learning disability. He came to our first evaluation due to macrocrania and a history of cognitive and behavioral impairment. Brain magnetic resonance was performed after this first visit, confirming macrocephaly and revealing type I Arnold-Chiari malformation, but neither hydrocephalus nor pituitary abnormalities. Genetic testing evaluating different genes involved in overgrowth syndromes revealed the novel variant c.7039C>T (p.Gln2347*) in the SETD2 gene, leading us to diagnose Luscan–Lumish syndrome, an autosomal dominant intellectual developmental disorder associated with protean overgrowth manifestations, including macrocephaly and dysmorphic features. Case-based Review of the Literature and Discussion: An extremely heterogeneous group of disorders with a wide range of etiologies, neurodevelopmental outcomes, and radiologic characteristics may be associated with individuals with macrocephaly. After initial clinical and neuroimaging assessment, a coherent diagnostic work-up should be customized for each case of macrocephaly to clarify an underlying condition and delineate prognosis. Genetic investigation should be considered mandatory in deciphering the inner architecture of macrocephalies and explaining any associated abnormalities that may cause either growth anomaly in se or its concurrent symptoms. Conclusions: A standard recognized classification system integrating clinical, neuroimaging, developmental biological criteria and molecular/genetic assessment of macrocephaly is not currently available; however, future investigations on patients with macrocephaly will help in understanding SETD2-related disorders and provide accurate genetic counseling for more targeted management strategies.

Diseases

18 November 2026

Frontal (A) and lateral (B) views of the patient; long feet (C) and truncal obesity with multiple nevi on the shoulder (D) were observed. The figures were obtained from the patient’s mother, legal guardian of the patient. The figures were used for phenotypic characterization of the case.
  • Systematic Review
  • Open Access

Background/Objectives: Retention in HIV care is essential for sustained treatment and viral suppression, yet evidence for educational and behavioral strategies remains inconsistent. The objective of this systematic review was to evaluate U.S.-based educational, behavioral, and supportive interventions designed to improve retention in HIV care or reduce loss to follow-up, while identifying methodological, population-level, and implementation-related evidence gaps. Methods: PubMed and Scopus were searched through 30 August 2025, CINAHL and PsycINFO through 20 September 2025, and Web of Science through 29 September 2025. Eligible studies were English-language, U.S.-based primary quantitative or mixed-methods research published from 2000 onward evaluating educational, counseling, behavioral, peer, coaching, digital, or navigation interventions among people with HIV. Non-U.S., non-English, non-human, non-primary, and qualitative-only studies were excluded. Risk of bias was assessed using design-specific Joanna Briggs Institute checklists. Findings were synthesized narratively using PICO and an evidence-gap framework. Results: Twenty-three studies (9177 participants) published from 2005–2025 were included; three had low, twelve had moderate, and eight had high risk of bias. Educational and behavioral strategies more consistently improved proximal outcomes than sustained retention. Enhanced personal contact produced the clearest controlled retention effect (visit constancy 55.8% vs. 45.7%; RR 1.22, 95% CI 1.09–1.36), whereas several trials were null. Multicomponent navigation and case-management programs showed favorable retention signals but limited component-specific attribution. Evidence was limited by heterogeneous retention definitions, methodological concerns, uneven population representation, and limited long-term and cost data. Conclusions: Education appears most useful when integrated with sustained personal, navigational, and social support.

Diseases

17 November 2026

PRISMA 2020 flow diagram of study identification, screening, eligibility assessment, and inclusion in the final U.S.-based evidence synthesis. The database searches identified 894 records. Following title/abstract and full-text screening, duplicate reconciliation, and secondary screening for U.S.-only eligibility, 23 unique studies met the prespecified eligibility criteria and were included in the final systematic review. Flow diagram adapted from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement [8].

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Diseases - ISSN 2079-9721